ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMSpese di vendita, generali e amministrative158.85 M157.23 M159.39 M152.77 M155.81 M154.57 M622.54 MRicerca e sviluppo22.36 M23.29 M21.87 M21.25 M21.09 M21.28 M85.48 MReddito operativo37.69 M12.89 M10.59 M13.72 M5.63 M13.58 M43.52 MProventi non operativi, Totale-6.02 M-1.76 M1.82 M607 K-894 K-1.06 M471 KOneri finanziari, al netto degli interessi capitalizzati34.24 M22.03 M20.55 M19.81 M30.95 M16.49 M87.8 MProventi non operativi, esclusi gli oneri finanziari-40.26 M-23.79 M-18.73 M-19.2 M-31.84 M-17.55 M-87.33 MEntrate/uscite straordinarie———————Utile al lordo delle imposte-66.01 M-10.91 M33.68 M-2.51 M1.87 M-3.98 M29.06 MQuota di utile002.84 M-1.54 M-2.48 M-607 K-1.8 MImposte32.05 M4.57 M1.18 M-658 K-2.65 M-34.71 M-36.85 MInteressi di minoranza———————Altri proventi/oneri al netto delle imposte—-557 K1.18 M-10.18 M—-2.99 M—Utile netto al lordo delle attività cessate-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MAttività cessate———————Utile netto-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MUtile base per azione (EPS base)-0.97-0.631.43-0.14-0.631.221.88Utile diluito per azione (EPS diluito)-0.97-0.631.43-0.14-0.631.21.86Numero medio di azioni ordinarie in circolazione24.39 M24.54 M24.64 M24.69 M24.64 M24.76 M—Azioni diluite in circolazione24.39 M24.54 M24.71 M24.69 M24.9 M25.18 M—EBITDA475.73 M62.33 M60.25 M64.52 M376.88 M63.61 M565.26 MEBIT422.84 M12.89 M10.59 M13.72 M326.05 M13.58 M363.94 MCosto del fatturato17.4 M394.59 M340.8 M336.11 M17.3 M324 M1.02 BAltri costi del venduto———————Ammortamento e svalutazione (liquidità)52.99 M49.45 M49.66 M50.8 M50.83 M50.03 M201.32 M
ICU Medical, Inc. - Common Stock
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine.